Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
In this update we added new monographs for ANSUVIMAB-ZYKL, IBUPROFEN LYSINE, OLICERIDINE, and SETMELANOTIDE.
We also added new stability information to these existing drug monographs: IDARUBICIN HYDROCHLORIDE, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and TRASTUZUMAB.
New compatibility information was added to these existing drug monographs: ACETAMINOPHEN with 12 other drugs; CLONIDINE HYDROCHLORIDE, IBUPROFEN LYSINE with 20 other drugs; LEVOBUPIVACAINE; MEROPENEM; MORPHINE HYDROCHLORIDE; RIFAMPIN, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL; and TEDIZOLID PHOSPHATE.